Browsing by Author Tambaki, A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 9 of 9
TitleAuthor(s)Issue date
Apolipoprotein a-I Amphipathic a-Helical Peptide Models: Effecton Ldl Oxidation in VitroSakarellos-Daitsiotis, M.; Alexopoulos, C. H.; Tambaki, A.; Harilogis, K.; Tselepis, A.; Sakarellos, C.24-Nov-2015
Apolipoprotein A-I amphipathic alpha-helical peptide models: effect on LDL oxidation in vitroSakarellos-Daitsiotis, M.; Alexopoulos, C.; Tambaki, A.; Harilogis, K.; Tselepis, A. D.; Sakarellos, C.24-Nov-2015
Beneficial effect of L-thyroxine on HDL-associated PAF-acetylhydrolase in patients with subclinical hypothyroidismMilionis, H.; Tambaki, A.; Kanioglou, C.; Tsatsoulis, A.; Tselepis, A.; Elisaf, M.24-Nov-2015
Does micronized fenofibrate affect PAF-Acetylhydrolase activity?Elisaf, M. E.; Tsimihodimos, V.; Bairaktari, E.; Tambaki, A.; Tselepis, A.; Papathanasiou, A.; Goudevenos, I.24-Nov-2015
Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein subfractions in patients with dyslipidemias of type IIA and IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A.; Bairaktari, E.; Achimastos, A.; Tselepis, A.; Elisaf, M. S.24-Nov-2015
Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein sulafractions in patients with dyslipidemias of type IIA and IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A.; Bairaktari, E.; Achimastos, A.; Tselepis, A.; Elisaf, M. S.24-Nov-2015
Effects of anithypertensive and hypolipidemic drugs on plasma and lipoprotein-associated PAF-acetylhydrolaseTsimihodimos, V.; Tambaki, A.; Rizos, E.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015
L-thyroxine treatment induces HDL-associated PAF-acetylhydrolase in patients with subclinical hypothyroidismMilionis, H.; Tambaki, A.; Kanioglou, C.; Elisaf, M.; Tsatsoulis, A.; Tselepis, A. D.24-Nov-2015
Reduced levels of HDL-associated PAF-acetylhydrolase activity in normolipidemic and dyslipidemic PON1 55LL carriersKakafika, A.; Tambaki, A.; Lourida, E.; Xenofontos, S.; Tsimihodimos, V.; Kalaitzidis, R.; Cariolou, M.; Elisaf, M.; Tselepis, A.24-Nov-2015